Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Informa Announces A New Award For Best Review Paper
The editors of Disability & Rehabilitation and its sister publication, Disability & Rehabilitation: Assistive Technology have announced an annual award which will be given for the best review paper published in either of the two journals. Commencing in 2009, the Informa Best Review Paper Award will recognise valuable, high-impact research in the fields of disability, rehabilitation and assistive technology.

Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial Of Picoplatin In Metastatic Colorectal Cancer
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). The new data demonstrated that picoplatin, given once every four weeks in combination with 5-fluorouracil and leucovorin in the FOLPI regimen, and oxaliplatin, given in combination with 5-fluorouracil and leucovorin in the modified FOLFOX-6 regimen, have similar anti-tumor activity in the treatment of first-line metastatic CRC, as assessed by progression-free survival (PFS) and disease control measured by tumor response rate. New data derived by three independent assessments of neurotoxicity indicated a statistically significant reduction in neurotoxicities with the use of picoplatin in FOLPI compared with oxaliplatin in FOLFOX (pPhase 2 CRC Trial Design and Updated Results
News of the day
State Assembly Approves Hayashi Legislation To Protect Consumers From Insurance Policy-Rescission
The California State Assembly has approved legislation by Assemblywoman Mary Hayashi (D-Hayward) that would prevent health plans and insurers from canceling a health insurance policy 18 months after the policy was issued. Assembly Bill 108 (Hayashi) passed on a 48-28 vote.
Oncology

Group Banned From Teaching Abstinence-Only Program In Sonoma County, Calif., Public Schools

Free to Be, a federally-funded organization in California that teaches abstinence-only sex education to students, is at the center of a debate with education officials and others in Sonoma County over whether their curriculum is in compliance with state rules requiring that sexual health education programs in public schools be "balanced" and include information on sexually transmitted infections such as HIV and contraception, the Santa Rosa Press Democrat reports. Sonoma County Office of Education officials in May banned the group from giving any further presentations on public school campuses, citing state law. Free to Be, as well as several school superintendents from around the county, said they are currently reviewing their legal options (Benefield, Santa Rosa Press Democrat, 6/7). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009